The absence of significant therapeutic effects associated with EGFR inhibition described here also correlates with results observed in the clinic [61], [74]–[76] using small molecule EGFR inhibitors, and in some pre-clinical GBM studies [77]–[79] using small molecule EGFR inhibitors or siRNA. Here, EGFR is linked to glioblastoma.